Levuspoz 50 & 100 50 mg, 100 mg Powder for solution for infusion
PDF Leaflet Revision Date: 25 July 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment and prophylaxis of invasive candidiasis.
Dosage (summary)
Adults: 100 mg/day for invasive candidiasis; 150 mg/day for oesophageal candidiasis; 50 mg/day for prophylaxis.
Special Populations
- Hepatic impairment
- Renal impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and lactation.
Key Drug Interactions
- Sirolimus (increased exposure)
Contraindications
- Hypersensitivity to micafungin
- Pregnancy
- Lactation
Common side effects
- Nausea
- Vomiting
- Phlebitis
- Increased liver enzymes
Counselling Points
- Monitor for liver function
- Avoid in pregnancy and breastfeeding
- Report any rash or allergic reactions
Serious warnings
- Risk of liver tumors
- Anaphylactic reactions
- Severe hepatic dysfunction
Important Disclaimer
The Levuspoz 50 & 100 50 mg, 100 mg Powder for solution for infusion professional information leaflet below is the property of Ranbaxy Pharmaceutical and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
